6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline

C152H123N19O — CID 158232453

IUPAC6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline
SMILESCc1ccc(-c2nc3ccccc3n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)o2)cc1.Cc1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1.Cc1nc2c3ccccc3c3ccccc3c2n1-c1ccccc1.Cc1nc2ccccc2n1-c1ccccc1.Cc1nc2ccccc2nc1-c1ccccc1.Cn1c(-c2ccccc2)nc2ccccc21.Cn1ccnc1-c1ccccc1
InChIInChI=1S/C22H16N2.C21H17N3.C21H16N2.C20H16N2.C15H12N2O.C15H12N2.2C14H12N2.C10H10N2/c1-15-23-21-19-13-7-5-11-17(19)18-12-6-8-14-20(18)22(21)24(15)16-9-3-2-4-10-16;1-16-12-14-18(15-13-16)21-23-22-20(17-8-4-2-5-9-17)24(21)19-10-6-3-7-11-19;1-15-12-13-18-19(14-15)23-21(17-10-6-3-7-11-17)20(22-18)16-8-4-2-5-9-16;1-15-11-13-16(14-12-15)20-21-18-9-5-6-10-19(18)22(20)17-7-3-2-4-8-17;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-11-15(12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11;1-16-13-10-6-5-9-12(13)15-14(16)11-7-3-2-4-8-11;1-11-15-13-9-5-6-10-14(13)16(11)12-7-3-2-4-8-12;1-12-8-7-11-10(12)9-5-3-2-4-6-9/h2-14H,1H3;2-15H,1H3;2-14H,1H3;2-14H,1H3;2-10H,1H3;2-10H,1H3;2*2-10H,1H3;2-8H,1H3
InChIKeyGENVIVPTDZBDSC-UHFFFAOYSA-N
MW2231.79 g/mol
LogP36.80
Rot. Bonds14

About 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline

6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline (PubChem CID 158232453) has the molecular formula C152H123N19O and a molecular weight of 2231.79 g/mol. Its IUPAC name is 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline.

Molecular Properties

Compound Name6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline
PubChem CID158232453
Molecular FormulaC152H123N19O
Molecular Weight2231.79 g/mol
Exact Mass2230.02
IUPAC Name6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline
SMILESCc1ccc(-c2nc3ccccc3n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)o2)cc1.Cc1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1.Cc1nc2c3ccccc3c3ccccc3c2n1-c1ccccc1.Cc1nc2ccccc2n1-c1ccccc1.Cc1nc2ccccc2nc1-c1ccccc1.Cn1c(-c2ccccc2)nc2ccccc21.Cn1ccnc1-c1ccccc1
InChIInChI=1S/C22H16N2.C21H17N3.C21H16N2.C20H16N2.C15H12N2O.C15H12N2.2C14H12N2.C10H10N2/c1-15-23-21-19-13-7-5-11-17(19)18-12-6-8-14-20(18)22(21)24(15)16-9-3-2-4-10-16;1-16-12-14-18(15-13-16)21-23-22-20(17-8-4-2-5-9-17)24(21)19-10-6-3-7-11-19;1-15-12-13-18-19(14-15)23-21(17-10-6-3-7-11-17)20(22-18)16-8-4-2-5-9-16;1-15-11-13-16(14-12-15)20-21-18-9-5-6-10-19(18)22(20)17-7-3-2-4-8-17;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-11-15(12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11;1-16-13-10-6-5-9-12(13)15-14(16)11-7-3-2-4-8-11;1-11-15-13-9-5-6-10-14(13)16(11)12-7-3-2-4-8-12;1-12-8-7-11-10(12)9-5-3-2-4-6-9/h2-14H,1H3;2-15H,1H3;2-14H,1H3;2-14H,1H3;2-10H,1H3;2-10H,1H3;2*2-10H,1H3;2-8H,1H3
InChIKeyGENVIVPTDZBDSC-UHFFFAOYSA-N
XLogP36.80
TPSA210.29 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds14
Heavy Atoms172
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002231.79
LogP ≤ 536.80
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline?
The IUPAC name of 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline (CID 158232453) is 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline.
What is the SMILES notation for 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline?
The canonical SMILES for 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline is Cc1ccc(-c2nc3ccccc3n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)n2-c2ccccc2)cc1.Cc1ccc(-c2nnc(-c3ccccc3)o2)cc1.Cc1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1.Cc1nc2c3ccccc3c3ccccc3c2n1-c1ccccc1.Cc1nc2ccccc2n1-c1ccccc1.Cc1nc2ccccc2nc1-c1ccccc1.Cn1c(-c2ccccc2)nc2ccccc21.Cn1ccnc1-c1ccccc1.
What is the InChIKey of 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline?
The InChIKey is GENVIVPTDZBDSC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H16N2.C21H17N3.C21H16N2.C20H16N2.C15H12N2O.C15H12N2.2C14H12N2.C10H10N2/c1-15-23-21-19-13-7-5-11-17(19)18-12-6-8-14-20(18)22(21)24(15)16-9-3-2-4-10-16;1-16-12-14-18(15-13-16)21-23-22-20(17-8-4-2-5-9-17)24(21)19-10-6-3-7-11-19;1-15-12-13-18-19(14-15)23-21(17-10-6-3-7-11-17)20(22-18)16-8-4-2-5-9-16;1-15-11-13-16(14-12-15)20-21-18-9-5-6-10-19(18)22(20)17-7-3-2-4-8-17;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-11-15(12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11;1-16-13-10-6-5-9-12(13)15-14(16)11-7-3-2-4-8-11;1-11-15-13-9-5-6-10-14(13)16(11)12-7-3-2-4-8-12;1-12-8-7-11-10(12)9-5-3-2-4-6-9/h2-14H,1H3;2-15H,1H3;2-14H,1H3;2-14H,1H3;2-10H,1H3;2-10H,1H3;2*2-10H,1H3;2-8H,1H3.
What are the key properties of 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline?
6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline has a molecular weight of 2231.79 g/mol, XLogP of 36.80, 14 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 6-methyl-2,3-diphenylquinoxaline;1-methyl-2-phenylbenzimidazole;2-methyl-1-phenylbenzimidazole;3-(4-methylphenyl)-4,5-diphenyl-1,2,4-triazole;1-methyl-2-phenylimidazole;2-methyl-3-phenylphenanthro[9,10-d]imidazole;2-(4-methylphenyl)-1-phenylbenzimidazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-methyl-3-phenylquinoxaline is sourced from PubChem (CID 158232453), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).